| |
| |
SPOT ON
|
| |
Anti-aging with testosterone?
|
| |
| |
THERAPIES FROM A CRITICAL VIEW POINT
|
| |
Memantine (AXURA) plus donepecil (ARICEPT)?
Glycoprotein IIb/IIIa receptor antagonist needless in coronary interventions?
|
| |
| |
NEW ON THE MARKET
|
| |
Eye drops for allergic conjunctivitis: olopatadin (OPATANOL) and epinastin (RELESTAT)
|
| |
| |
REVIEW
|
| |
VValue of montelukast (SINGULAIR) in asthma
|
| |
| |
ORIGINAL ARTICLE
|
| |
How accurate are advertisements?
|
| |
| |
a-t READERS' QUESTIONS AND COMMENTS
|
| |
Clopidogrel (ISCOVER, PLAVIX): Which applications are established?
|
| |
| |
IN BRIEF
|
| |
Attention: Incorrectly low prices for simvastatine-generics
No hormon therapy for women with breast cancer
Exercise training in patients with chronic heart failure
Pancreatic carcinoma under taking ASPIRIN?
|
 |
Homocysteine: Vitamins without influence on recurrent stroke |
| |
| |
SIDE EFFECTS
|
| |
Butterbur (PETADOLEX) off market in Switzerland
Fatalities under antirheumatic drug leflunomid (ARAVA)
|
| |
| |
CURRENT ADR NETWORK REPORT
|
| |
Shock under fluoroquinolone moxifloxacine (AVALOX)
|
| |